Exocrine Pancreatic Insufficiency Market | Business Growth, Development Factors, Current and Future Trends till 2029

 Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the exocrine pancreatic insufficiency sector.

 



 Exocrine Pancreatic Insufficiency Market Analysis & Forecast: 2025–2029
 The exocrine pancreatic insufficiency market size has grown strongly in recent years. It will grow from $2.59 billion in 2024 to $2.75 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased awareness and diagnosis, growing prevalence of digestive disorders, aging population, and pancreatic function decline, rise in gastrointestinal surgeries.
 
 The exocrine pancreatic insufficiency market size is expected to see strong growth in the next few years. It will grow to $3.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to continued increase in awareness and screening, expanding geriatric population, rising incidence of chronic diseases, improvements in patient access to healthcare, research and development in digestive health. Major trends in the forecast period include telehealth and digital health solutions, collaborative research initiatives, focus on pediatric epi, regulatory advances and fast-track designations, market expansion in emerging economies, advancements in healthcare infrastructure.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp
 
 What Are The Factors Driving The Exocrine Pancreatic Insufficiency Market?
 The rise in chronic diseases is expected to propel the growth of the exocrine pancreatic insufficiency market going forward. Chronic diseases are long-term medical conditions that persist over an extended period, typically three months or more. The prolonged presence of the underlying disease can also increase the likelihood of developing secondary complications like exocrine pancreatic insufficiency, which fuels the better management of chronic conditions through medical interventions and therapies and can lead to longer life spans for individuals with these conditions. For instance, In September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths occur annually, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases worldwide. Therefore, the rise in chronic diseases will drive the growth of the exocrine pancreatic insufficiency market. 
 
 What Segments Are Covered In The Exocrine Pancreatic Insufficiency Market Report?
 The exocrine pancreatic insufficiencymarket covered in this report is segmented — 
 
 1) By Treatment: Nutritional Management; Pancreatic Enzyme Replacement Therapy (PERT); Other Treatments
 2) By Diagnosis: Imaging Tests; Computed Tomography (CT) Scan; Abdominal Ultrasound; Secretin Pancreatic Function Test; Fecal Fat Test; Fecal Elastase Test (FE-1); Other Types
 3) By Symptoms: Abdominal Pain; Constipation; Diarrhea; Fatty Stools; Weight Loss; Other Symptoms
 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
 5) By End Users: Hospitals; Specialty Clinics; Homecare
 
 Subsegments:
 1) By Nutritional Management: Dietary Modifications; Nutritional Supplements
 2) By Pancreatic Enzyme Replacement Therapy (PERT): Enteric-Coated Capsules; Non-Enteric-Coated Capsules; Powder Formulations
 3) By Other Treatments: Medications; Surgical Interventions; Supportive Therapies
 
 What Are The Main Trends, Positively Impacting The Growth Of Exocrine Pancreatic Insufficiency Market?
 Major companies operating in the exocrine pancreatic insufficiency market are focusing on creating patient advocacy groups such as comprehensive nutritional guidance to provide comprehensive nutritional guidance and support. These initiatives aim to improve awareness, education, and management of the condition among affected individuals. Comprehensive nutritional guidance is a holistic approach that tailors dietary recommendations based on individual needs, health conditions, and lifestyle. It emphasizes education, meal planning, and sustainable practices to promote overall well-being. For instance, in June 2024, Nestlé Health Science, a Switzerland-based nutrition company, launched a GLP-1 nutrition support platform. Nestlé Health Science’s GLP-1 nutrition support platform offers tailored nutritional resources and expert guidance for individuals using GLP-1 medications, focusing on muscle preservation, gut health, and overall wellness. Its purpose is to empower users in their weight management journey by addressing unique dietary needs and fostering community support. 
 
 Which Are The Major Players Operating In The Global Exocrine Pancreatic Insufficiency Market?
 Major companies operating in the exocrine pancreatic insufficiency market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Nestle Health Science S.A., Allergan PLC, Chiesi Farmaceutici S.p.A., Wockhardt Ltd., Amryt Pharma PLC, Codexis Inc., Nordmark Arzneimittel GmbH & Co. KG, Aimmune Therapeutics Inc., Digestive Care Inc., Enzymedica Inc., Vivus Inc., Alcresta Therapeutics Inc., Cilian AG, Perseo Pharma AG, Enzyme Development Corporation, First Wave BioPharma Inc., Synspira Therapeutics 
 
 View the full exocrine pancreatic insufficiency market report here:
 https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report
 
 Exocrine Pancreatic Insufficiency Market Regional Insights:
 North America was the largest region in the exocrine pancreatic insufficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exocrine pancreatic insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more